130 related articles for article (PubMed ID: 10790758)
1. Pathogenesis of anaemia in hyperparathyroidism.
Sikole A
Med Hypotheses; 2000 Feb; 54(2):236-8. PubMed ID: 10790758
[TBL] [Abstract][Full Text] [Related]
2. Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies.
Grützmacher P; Radtke HW; Fassbinder W; Koch KM; Schoeppe W
Proc Eur Dial Transplant Assoc; 1983; 20():739-45. PubMed ID: 6657694
[TBL] [Abstract][Full Text] [Related]
3. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis.
Delwiche F; Garrity MJ; Powell JS; Robertson RP; Adamson JW
J Lab Clin Med; 1983 Oct; 102(4):613-20. PubMed ID: 6311928
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of the anemia of uremia: role of secondary hyperparathyroidism.
Massry SG
Kidney Int Suppl; 1983 Dec; 16():S204-7. PubMed ID: 6376915
[TBL] [Abstract][Full Text] [Related]
5. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.
Drüeke TB; Eckardt KU
Nephrol Dial Transplant; 2002; 17 Suppl 5():28-31. PubMed ID: 12091604
[TBL] [Abstract][Full Text] [Related]
6. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
Trunzo JA; McHenry CR; Schulak JA; Wilhelm SM
Surgery; 2008 Dec; 144(6):915-8; discussion 919. PubMed ID: 19040997
[TBL] [Abstract][Full Text] [Related]
7. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.
Brancaccio D; Cozzolino M; Gallieni M
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S21-4. PubMed ID: 14684666
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and anaemia--an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism.
Foulks CJ; Mills GM; Wright LF
Postgrad Med J; 1989 Mar; 65(761):136-9. PubMed ID: 2813231
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
Brunner S; Theiss HD; Murr A; Negele T; Franz WM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
[TBL] [Abstract][Full Text] [Related]
11. Anaemia in primary hyperparathyroidism--fantasy or reality.
Abarca J; Trigonis C; Hamberger B; Granberg PO
Ann Chir Gynaecol; 1985; 74(2):74-6. PubMed ID: 4026178
[TBL] [Abstract][Full Text] [Related]
12. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
[TBL] [Abstract][Full Text] [Related]
13. Laboratory screening for hyperparathyroidism.
Younes NA; Shafagoj Y; Khatib F; Ababneh M
Clin Chim Acta; 2005 Mar; 353(1-2):1-12. PubMed ID: 15698586
[TBL] [Abstract][Full Text] [Related]
14. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
15. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
17. Plasma parathyroid hormone and erythropoietin levels in patients with noninflammatory acute renal failure.
Kokot F; Wiecek A; Grzeszczak W
Int Urol Nephrol; 1993; 25(1):89-96. PubMed ID: 8514479
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
19. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease.
Alfrey CP; Fishbane S
Nephron Clin Pract; 2007; 106(4):c149-56. PubMed ID: 17596723
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-dependent erythropoiesis: New insights and questions.
Wojchowski DM; Menon MP; Sathyanarayana P; Fang J; Karur V; Houde E; Kapelle W; Bogachev O
Blood Cells Mol Dis; 2006; 36(2):232-8. PubMed ID: 16524748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
